Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MADD | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | RALGPS1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | PPP1R12C | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | DDX27 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | USF2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | RP11-949J7.8 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | CMSS1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | RINT1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | ZNF135 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | NEK2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |